The latest news updates from the 2024 Symposium
-
Countdown to 2020 SABCS: Don’t miss a minute of Virtual SABCS!
Read More: Countdown to 2020 SABCS: Don’t miss a minute of Virtual SABCS!Worried about missing a key session or learning about trending topics? With four full days of programming, it can be easy for amazing sessions to slip under the radar. We have you covered! Following are just a few of the many daily programs you won’t want to miss.
-
Plenary Lectures part of SABCS on-demand programming
Read More: Plenary Lectures part of SABCS on-demand programmingBeginning at 8:00 am CT on Wednesday, Dec. 9, SABCS registrants will have access to a variety of special on-demand programming, including this year’s two must-watch Plenary Lectures which will be presented by Elizabeth A. Mittendorf, MD, PhD, and Norman E. “Ned” Sharpless, MD.
-
Spend some time in the SABCS Virtual Exhibit Hall
Read More: Spend some time in the SABCS Virtual Exhibit HallBe sure to make some time in your SABCS virtual schedule to visit the Virtual Exhibit Hall to learn about the latest in products and services related to breast cancer research and treatment. The SABCS Virtual Exhibit Hall will be open from 10:00 am to 3:00 pm CT each day of the Symposium.
-
Scholarships provide assistance to early-career physicians, scientists and researchers
Read More: Scholarships provide assistance to early-career physicians, scientists and researchersResearchers from across the globe will participate and present their work during the 2020 SABCS Virtual Symposium with the help of scholarships awarded through SABCS and co-sponsor, the American Association for Cancer Research (AACR).
-
SABCS accreditation and CME information
Read More: SABCS accreditation and CME informationThe Joe R. and Teresa Lozano Long San Antonio School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.The Long School of Medicine designates this live activity up to a maximum of 46.75 AMA PRA Category 1 Credits™.